Received: 26 August 2020
Accepted: 13 February 2021
First Online: 8 March 2021
Ethics approval and consent to participate
: The CULPRIT-SHOCK trial was approved by a multi-site ethics committee and for all eligible patients, written informed consent was obtained with the use of a prespecified process that varied slightly according to country.
: Not applicable.
: There are no competing interests.